RxDoctor Payments Data

Juan Ceja Solorio, DPM

Foot & Ankle Surgery · Meridian, IDNPI 1912529306

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (44.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Kairos Surgical Inc at 45.1% of the total.

$5,395in general payments, 2019–2025

Across 57 payments — averaging $94.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$2K
  • Stryker$2K
  • Integra Lifesciences Corporation$559
  • Smith+Nephew$254
  • Carbofix Orthopedics Inc$138
  • Sawtooth Surgical Solutions Inc$60
  • plus $52 from 2 others

What the payments were for

  • Travel & lodging$1,09320%
  • Food & beverage$1,87735%
  • Education$2,42545%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Kairos Surgical Inc4$2,434
Stryker26$1,898
Integra Lifesciences Corporation11$559
Smith+Nephew10$254
Carbofix Orthopedics Inc1$138
Sawtooth Surgical Solutions Inc2$60
Bioventus LLC2$38
Solventum Corporation1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,395 in reported general payments places this provider in the 65th percentile of 49 foot & ankle surgery providers in Idaho.

See all foot & ankle surgery providers in Idaho

Medicare billing

Part B allowed, 2024
$40,839
Medicare patients
259
Services billed
564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox25$925
Methylprednisolone23$143
Meloxicam19$55

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Meridian

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →